Medicine Prices Rise in Rawalpindi, Patients Face Burden

March 29, 2026

Islamabad, March 29: Residents of Rawalpindi are facing increasing financial pressure as the prices of medicines have surged, making essential healthcare more expensive for patients. The rise in costs has particularly impacted individuals suffering from chronic illnesses who rely on regular medication.

Patients Struggle to Afford Essential Drugs

The price hike has affected a wide range of medicines, including those used for diabetes, heart conditions, and general health supplements. Many patients have reported difficulty in continuing treatment due to rising costs, forcing some to reduce dosage or delay medication purchases. Recent reports indicate that prices of essential drugs across Pakistan have seen noticeable increases, adding to the burden on households already dealing with inflation.

Concerns Over Regulation and Pricing Policies

Experts point out that pricing policies, currency fluctuations, and supply chain issues are major factors contributing to the increase. Regulatory authorities have faced criticism for allowing price adjustments without adequate safeguards for consumers. Healthcare professionals warn that unchecked price hikes could limit access to life-saving medicines, especially for low-income families.

Calls for Government Intervention

Citizens and health experts are urging authorities to regulate medicine prices more strictly and ensure availability at affordable rates. Suggestions include price caps, subsidies for essential drugs, and improved monitoring of pharmaceutical companies.

Impact on Healthcare System

The rising cost of medicines is not only affecting individuals but also placing pressure on the broader healthcare system. Hospitals and clinics may see an increase in untreated cases as patients struggle to afford prescriptions. Experts stress that ensuring affordable access to medicines is crucial for public health and requires coordinated action from both the government and the pharmaceutical industry.